| |
|
|
|
Redhill Biophrma ADR  
|
|
7.91 0.27 (0.04%) |
01-25 16:00 |
|
Open: |
7.74 |
Pre close: |
7.64 |
Target:
|
10.27
|
|
High: |
8.2442 |
Low: |
7.69 |
Resistance:
|
8.79
9.99
|
|
Volume: |
749,706 |
Market Cap: |
329M |
Support:
|
6.85
5.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.77
 |
MACD |
MACD(12,26):
|
-0.27 |
|
MA(20): |
8.17  |
Signal(12,26,9): |
-0.25 |
|
MA(100): |
8.97 |
Stochastic Oscillator |
%K(14,3):
|
41.34 |
|
MA(250): |
7.42 |
%D(3): |
36.18 |
|
Average Volume(K) |
3-Month: |
34055
|
52-Week |
High:
|
11.35 |
|
10-Days: |
64070 |
Low: |
3.26 |
|
RSI |
RSI(14):
|
45.92 |
Change(%): |
38.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.800 |
Return on Equity (ttm) |
-246.3 |
Shares Out. (M) |
37.41 |
|
EPS Est. Current Year |
-2.390 |
Return on Assets (ttm) |
-32.8 |
Shares Float (M) |
22.88 |
|
EPS Est. Next Year |
-0.540 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.29 |
|
EPS Est. Next Quarter |
-0.620 |
Qtrly Rev. Growth |
1394.9 |
% Held by Institutions |
23.38 |
|
Forward EPS |
1.700 |
Gross Profit (p.s.) |
0.108 |
Shares Short (K) |
1950 |
|
Book Value (p.s.) |
0.770 |
EBITDA (p.s.) |
-1.342 |
P/E |
-4.39 |
|
Sales Per Share |
1.189 |
Qtrly Earnings Growth |
0.00 |
P/BV |
10.27 |
|
Profit Margin |
-142.81 |
Operating Cash Flow
(M) |
-49.74 |
P/S |
6.65 |
|
Operating Margin |
-123.49 |
Levered Free Cash Flow
(M) |
-83.64 |
P/CF |
-5.95 |
|
|
|
|
|
|
